# A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT02040792** · PHASE2 · COMPLETED · sponsor: **Mylan Inc.** · enrollment: 355 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** TD-4208
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02040792
- **Lead sponsor:** Mylan Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-07
- **Final completion:** 2014-08
- **Target enrollment:** 355 (ACTUAL)
- **Last updated:** 2022-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02040792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02040792, "A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02040792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*